Menu Search
Equities

Ems Chemie Holding AG

EMC1:BRN

Ems Chemie Holding AG

Actions
  • Price (CHF)627.60
  • Today's Change-1.32 / -0.21%
  • Shares traded61.00
  • 1 Year change+1.38%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

EMS-CHEMIE HOLDING AG is a Switzerland-based holding company and producer and supplier of polymers and chemicals. The Company operates in two business segments: High Performance Polymers and Specialty Chemicals. The High Performance Polymers business segment comprises EMS-GRIVORY, a manufacturer of high-performance polyamides and the supplier of a range of polyamide materials, and EMS-EFTEC, a supplier of adhesives, sealants and coatings including application engineering systems for the automotive industry worldwide. The Specialty Chemicals business segment includes EMS-PATVAG, which specializes in igniters for airbag gas generators, and EMS-GRILTECH, which manufactures and sells Grilon, Nexylon and Nexylene fibers, Griltex hotmelt adhesives, Grilbond adhesion promoters, Primid crosslinkers for powder-coatings and Grilonit reactive diluents. The Company operates through its subsidiaries in Europe, Asia, North and South America, and has 26 production sites in 16 different countries.

  • Revenue in CHF (TTM)2.09bn
  • Net income in CHF461.97m
  • Incorporated1962
  • Employees2.77k
  • Location
    Ems Chemie Holding AGFuederholzstrasse 34HERRLIBERG 8704SwitzerlandCHE
  • Phone+41 449157000
  • Fax+41 449157002
  • Websitehttps://www.ems-group.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.